» Articles » PMID: 33854501

Integrin Activation Enables Sensitive Detection of Functional CD4 and CD8 T Cells: Application to Characterize SARS-CoV-2 Immunity

Overview
Journal Front Immunol
Date 2021 Apr 15
PMID 33854501
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously shown that conformational change in the β-integrin is a very early activation marker that can be detected with fluorescent multimers of its ligand intercellular adhesion molecule (ICAM)-1 for rapid assessment of antigen-specific CD8 T cells. In this study, we describe a modified protocol of this assay for sensitive detection of functional antigen-specific CD4 T cells using a monoclonal antibody (clone m24 Ab) specific for the open, high-affinity conformation of the β-integrin. The kinetics of β-integrin activation was different on CD4 and CD8 T cells (several hours vs. few minutes, respectively); however, m24 Ab readily stained both cell types 4-6 h after antigen stimulation. With this protocol, we were able to monitor effector and memory CD4 and CD8 T cells specific for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), cytomegalovirus (CMV), Epstein-Barr virus (EBV), and hepatitis B virus (HBV) in whole blood or cryopreserved peripheral blood mononuclear cells (PBMCs) of infected or vaccinated individuals. By costaining β-integrin with m24 and CD154 Abs, we assessed extremely low frequencies of polyfunctional CD4 T cell responses. The novel assay used in this study allows very sensitive and simultaneous screening of both CD4 and CD8 T cell reactivities, with versatile applicability in clinical and vaccination studies.

Citing Articles

Staining of activated ß-integrins in combination with CD137 and CD154 for sensitive identification of functional antigen-specific CD4 and CD8 T cells.

Schollhorn A, Maia A, Kimmerle F, Born J, Rammensee H, Dimitrov S Front Immunol. 2023; 13:1107366.

PMID: 36741378 PMC: 9892897. DOI: 10.3389/fimmu.2022.1107366.


Adaptive immunity to SARS-CoV-2 infection: A systematic review.

Silva M, Ribeiro L, Lima K, Lima L Front Immunol. 2022; 13:1001198.

PMID: 36300105 PMC: 9589156. DOI: 10.3389/fimmu.2022.1001198.


Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions.

Saratale G, Shin H, Shinde S, Kim D, Saratale R, Kadam A J Pers Med. 2022; 12(3).

PMID: 35330349 PMC: 8955701. DOI: 10.3390/jpm12030349.


Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis.

Asplund Hogelin K, Ruffin N, Pin E, Manberg A, Hober S, Gafvelin G iScience. 2021; 24(9):103078.

PMID: 34490414 PMC: 8410640. DOI: 10.1016/j.isci.2021.103078.

References
1.
Bert N, Tan A, Kunasegaran K, Tham C, Hafezi M, Chia A . SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020; 584(7821):457-462. DOI: 10.1038/s41586-020-2550-z. View

2.
Hadrup S, Bakker A, Shu C, Andersen R, van Veluw J, Hombrink P . Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat Methods. 2009; 6(7):520-6. DOI: 10.1038/nmeth.1345. View

3.
Frentsch M, Arbach O, Kirchhoff D, Moewes B, Worm M, Rothe M . Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med. 2005; 11(10):1118-24. DOI: 10.1038/nm1292. View

4.
Becattini S, Latorre D, Mele F, Foglierini M, De Gregorio C, Cassotta A . T cell immunity. Functional heterogeneity of human memory CD4⁺ T cell clones primed by pathogens or vaccines. Science. 2014; 347(6220):400-6. DOI: 10.1126/science.1260668. View

5.
Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Rydyznski Moderbacher C . Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020; 181(7):1489-1501.e15. PMC: 7237901. DOI: 10.1016/j.cell.2020.05.015. View